Tahir Amin: Transparency in Drug Pricing
Tahir Amin: Pay-for-Delay Settlements and Patient Access
Tahir Amin: The Role of Advocacy Groups in the Patent System
Gilead patent for its Sovaldi hepatitis C drug is rejected in Ukraine
Ready to Leave the Private Sector for Public Service? Read This First.
Another reason to visit Egypt: Europe’s high drug prices
The Loopholes Drug Companies Use to Keep Prices High
Non-profit group continues battle against Gilead patents
Medicines access group takes aim at Sovaldi patents
Patent ‘Trolls’ Recede as Threat to Innovation. Will Justices Change That?